• Home
  • Shenzhen Haorui Industrial Dev. Co. Ltd.

Shenzhen Haorui Industrial Dev. Co. Ltd.

About Shenzhen Haorui Industrial Dev. Co. Ltd.

Haorui, established in 1997, is a manufacturer and supplier of APIs, intermediates, veterinary and food additives. Meanwhile, it is assisting global pharmaceutical companies to get the domestic registration of their finished dosage for their international expansion. Our USFDA approved products Flumazenil, Granisetron HCl, Granisetron Base, Docetaxel Anhydrous, Irinotecan HCl, Dasatinib M...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
View company profile
Contact info
  • 075582960263
  • Website
  • RM503, WANHAI BUILDING B, NANHAI AVENUE, NANSHAN District, Shenzhen 518067 China, 518067, Shenzhen, Guangdong, China
Show contact info Hide contact info

Products from Shenzhen Haorui Industrial Dev. Co. Ltd. (3)

  • Dasatinib

    Product Dasatinib

    CAS: 302962-49-8Specification: IHS
    It has a role as a tyrosine kinase inhibitor, an anticoronaviral agent and an antineoplastic agent.
    Regulatory status: USDMF No.34875, local GMP available

  • Docetaxel anhydrous

    Product Docetaxel anhydrous

    CAS: 114977-28-5Docetaxel is a clinically well established anti-mitotic chemotherapy medication used for the treatment of different types of cancer, including breast, ovarian, and non-small cell lung cancer.
    Regulatory status: USDMF No.22562, USFDA Approved, EU GMP
    CEP: R0-CEP 2021-302-Rev ...
  • Irinotecan hydrochloride

    Product Irinotecan hydrochloride

    CAS: 100286-90-6Used (in the form of its trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
    Regulatory status: 
    USDMF No.23522, USFDA Approve...